• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long term persistence with statin therapy -- experience in Australia 2006-2010.

作者信息

Simons Leon A, Ortiz Michael, Calcino Gordon

机构信息

University of New South Wales, St Vincent's Hospital, New South Wales.

出版信息

Aust Fam Physician. 2011 May;40(5):319-22.

PMID:21597553
Abstract

BACKGROUND

Long term persistence on statin drugs has been shown to be unsatisfactory, however, there is little recent Australian data. This study examines current persistence Australia-wide in patients who have been newly prescribed a statin drug.

METHOD

We conducted a longitudinal assessment of Pharmaceutical Benefit Scheme claim records dating from April 2005 to March 2010. Main outcome measures were the proportion of patients who were not filling a first repeat prescription at 1 month, and median persistence time during follow up.

RESULTS

For 77,867 patients initiated to statin, 86% of prescriptions came from general practitioners. Forty-three percent of patients discontinued statin within 6 months, 23% failed to collect their first repeat at 1 month, and median persistence time was only 11 months. In those aged 65--74 years, median persistence time was 19 months but only 3--6 months for those less than 55 years.

DISCUSSION

Unsatisfactory long term persistence on statin therapy has changed little over the past 10 years. There may be an opportunity for early intervention within 3--4 weeks of initiation to improve persistence, as valuable resources are being wasted and an opportunity for disease prevention missed.

摘要

相似文献

1
Long term persistence with statin therapy -- experience in Australia 2006-2010.
Aust Fam Physician. 2011 May;40(5):319-22.
2
Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.以色列一家非营利性健康维护组织中他汀类药物治疗的长期持续性:一项基于人群的回顾性队列研究
Clin Ther. 2008 Nov;30(11):2167-79. doi: 10.1016/j.clinthera.2008.11.012.
3
Persistence on warfarin in patients with atrial fibrillation: experience in Australia 2006-2009.心房颤动患者对华法林的持续使用情况:2006 - 2009年澳大利亚的经验
Aust Fam Physician. 2013 Sep;42(9):659-61.
4
Long-term persistence with statin therapy: a nationwide register study in Finland.他汀类药物治疗的长期持续性:芬兰的一项全国性登记研究
Clin Ther. 2008;30 Pt 2:2228-40. doi: 10.1016/j.clinthera.2008.12.003.
5
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.意大利日常临床实践中他汀类药物治疗依从性与非致命性缺血性心脏病风险的回顾性数据库分析结果。
Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.
6
Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.新开始阿托伐他汀或辛伐他汀治疗的患者的心血管结局:美国管理式医疗计划的大型数据库分析
Clin Ther. 2008 Jan;30(1):195-205. doi: 10.1016/j.clinthera.2008.01.003.
7
Impact of concurrent medication use on statin adherence and refill persistence.
Arch Intern Med. 2004 Nov 22;164(21):2343-8. doi: 10.1001/archinte.164.21.2343.
8
Is there a relationship between early statin compliance and a reduction in healthcare utilization?早期他汀类药物依从性与医疗保健利用减少之间是否存在关系?
Am J Manag Care. 2010 Jun;16(6):459-66.
9
Effect of statin adherence on cerebrovascular disease in primary prevention.他汀类药物依从性对一级预防中脑血管疾病的影响。
Am J Med. 2009 Jul;122(7):647-55. doi: 10.1016/j.amjmed.2009.01.032.
10
[Long-term treatment with statins in patients with ischemic heart disease after coronary angioplasty].[冠状动脉成形术后缺血性心脏病患者的他汀类药物长期治疗]
Vnitr Lek. 2003 Apr;49(4):285-90.

引用本文的文献

1
Life, death, and statins: association of statin prescriptions and survival in older general practice patients.他汀类药物与老年人全因死亡率的相关性:他汀类药物处方与生存的关联。
Prim Health Care Res Dev. 2024 May 16;25:e29. doi: 10.1017/S1463423624000161.
2
Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data.他汀类药物治疗的转换、持续性和依从性:一项使用澳大利亚国家药房数据的回顾性队列研究。
Cardiovasc Drugs Ther. 2022 Oct;36(5):867-877. doi: 10.1007/s10557-021-07199-7. Epub 2021 Jun 7.
3
The changing face of Australian data reforms: impact on pharmacoepidemiology research.
澳大利亚数据改革的面貌变化:对药物流行病学研究的影响。
Int J Popul Data Sci. 2021 Apr 15;6(1):1418. doi: 10.23889/ijpds.v6i1.1418.
4
Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.老年人他汀类药物第一年不依从和停药的预测因素:一项回顾性队列研究。
Br J Clin Pharmacol. 2019 Jan;85(1):227-235. doi: 10.1111/bcp.13797. Epub 2018 Nov 8.
5
Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia.老年痴呆症患者中他汀类药物的使用情况、患病率和发病率,以及 3 年的依从性和停药率。
Am J Alzheimers Dis Other Demen. 2018 Dec;33(8):527-534. doi: 10.1177/1533317518787314. Epub 2018 Jul 10.
6
Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?仅片剂剂型就能提高依从性和持续性吗:依折麦布固定剂量复方制剂与依折麦布分开片剂联合用药的比较?
Br J Clin Pharmacol. 2017 Jan;83(1):202-210. doi: 10.1111/bcp.13088. Epub 2016 Sep 29.
7
Overcoming Challenges With Statin Therapy.他汀类药物治疗面临的挑战及应对策略
J Am Heart Assoc. 2016 Jan 27;5(1):e002497. doi: 10.1161/JAHA.115.002497.
8
The Choice of Analytical Strategies in Inverse-Probability-of-Treatment-Weighted Analysis: A Simulation Study.治疗权重逆概率分析中分析策略的选择:一项模拟研究
Am J Epidemiol. 2015 Sep 15;182(6):520-7. doi: 10.1093/aje/kwv098. Epub 2015 Aug 26.
9
The burden of non-adherence to cardiovascular medications among the aging population in Australia: a meta-analysis.澳大利亚老年人群中不遵医嘱服用心血管药物的负担:一项荟萃分析。
Drugs Aging. 2015 Mar;32(3):217-25. doi: 10.1007/s40266-015-0245-1.
10
Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocol.西澳大利亚老年人心脏病二级预防药物的长期使用及成本效益(WAMACH):一项研究方案
BMJ Open. 2014 Sep 18;4(9):e006258. doi: 10.1136/bmjopen-2014-006258.